Inventor · disambiguated record
Eric Pamer
Also filed as: PAMER ERIC · PAMER ERIC G · PAMER ERIC GERD
11 granted patents·13 pending applications·17 citations·filing 2012–2024
85Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER15UNIV CHICAGO4SCHER JOSE U3ABRAMSON STEVEN B1SLOAN KETTERING INST CANCER1
Top patents by PatentIndex Score
24 records- 0187US10646520B2Methods and compositions for reducing vancomycin-resistant Enterococci infection or colonizationMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted May 12, 2020·3 cites·19 claims
- 0286US11471495B2Methods and compositions for reducing Clostridium difficile infectionMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Oct 18, 2022·4 cites·16 claims
- 0384US11207374B2Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Dec 28, 2021·3 cites·20 claims
- 0481US11197897B2Methods and compositions for reducing vancomycin-resistant enterococci infection or colonizationMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Dec 14, 2021·1 cites·21 claims
- 0580US10226443B2Methods for treating psoriatic arthritisSCHER JOSE U·Filed 2015·Granted Mar 12, 2019·6 cites·6 claims
- 0675US12414969B2Methods and compositions for reducing clostridium difficile infectionMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Sep 16, 2025·0 cites·18 claims
- 0772US12257284B2Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Mar 25, 2025·0 cites·20 claims
- 0871US2024374655A1Intestinal microbiota and gvhdMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0969US2024210395A1Methods and compositions for identifying and treating subjects at risk for poor car t cell therapy responseMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1067US2022096567A1Methods and compositions for reducing vancomycin-resistant enterococci infection or colonizationMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1166US2025186470A1Compositions and Methods Using Lactulose for Treating DiseaseUNIV CHICAGO·Filed 2024·Application pending·0 cites
- 1266US2024068007A1Biomarkers of risk for infectionUNIV CHICAGO·Filed 2023·Application pending·0 cites
- 1365US2025325599A1A clinical isolated avirulent strain protects against wildtype virulent clostridioides difficile infectionUNIV CHICAGO·Filed 2023·Application pending·0 cites
- 1463US2021369795A1Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitisMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1563US2024344105A1Methods for determining risk of mortality from covid-19UNIV CHICAGO·Filed 2023·Application pending·0 cites
- 1658US11860163B2Methods and compositions for identifying and treating subjects at risk for poor CAR T cell therapy responseMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Jan 2, 2024·0 cites·15 claims
- 1750US11045506B2Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitisMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jun 29, 2021·0 cites·6 claims
- 1849US11364269B2Methods and compositions for reducing Listeria monocytogenes infection or colonizationMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Jun 21, 2022·0 cites·12 claims
- 1949US2017258854A1Intestinal microbiota and gvhdMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Application pending·0 cites
- 2049US2017087196A1Methods and compositions for reducing clostridium difficile infectionMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Application pending·0 cites
- 2144US2015167084A1Quantitative Assessment of Human T-Cell Repertoire Recovery After Allogeneic Hematopoietic Stem Cell TransplantationSLOAN KETTERING INST CANCER·Filed 2013·Application pending·0 cites
- 2242US2016186261A1Prevotella copri and enhanced susceptibility to arthritisSCHER JOSE U·Filed 2014·Application pending·0 cites
- 2338US10011883B2Causative agents and diagnostic methods relating to rheumatoid arthritisABRAMSON STEVEN B·Filed 2012·Granted Jul 3, 2018·0 cites·16 claims
- 2430US2015374760A1Methods for treating psoriasis and psoriatic arthritisSCHER JOSE U·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →